Toad venom drug
A little-known psychedelic drug may improve depression and anxiety when administered in a structured group setting, new research suggests. Investigators studied over 350 adults who took 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) — a rapid-acting synthetic psychedelic derived from toad venom with short duration of psychedelic effects — in a group ceremonial environment. The drug comes from a rare species of toad native to the Sonoran Desert, Bufo Alvarius, which produces a venom known as 5-MeO-DMT: an extremely potent natural psychedelic. 5-MeO-DMT is about four to six times more powerful than its better-known cousin DMT (dimethyltryptamine). buy toad venom, toad venom for sale,
Toad Venom: New Possible Treatment for Depression?
Once the venom wears off, users say that they experience an afterglow that can trigger them to make major, positive life changes. 5-MeO-DMT appears to have a placebo analgesic effect comparable to hypnosis. The drug has shown to help break attachments to past trauma, negative behaviors, and habitual negative thought patterns. toad venom psychedelic
Such beneficial psychological effects has led some researchers to believe that in a controlled setting with a well-trained professional, the venom could be useful in treating anxiety and depression. In fact, preliminary studies performed by John Hopkins University suggest that it may combat depression and anxiety just as effectively as psilocybin, in addition to requiring a much shorter duration of time to reap the therapeutic benefits. Davis believes the 5-MeO-DMT found in toad venom is effective at treating these mental illnesses due to a combination of neurological changes in users’ brains and insights they gained through the psychedelic experience. Davis hopes that the research that is being performed at John Hopkins will inspire other people to follow suit and explore the option of using psychedelics as possible treatment options. buy toad venom
Why Do People Get High after smoking toad venom?
Psychedelic toad venom (reportedly) produces mystical experiences on par with psilocybin, but for a much shorter duration — on average for 20-minutes. It does not produce the same kind of visual trips that mushrooms or DMT do. Most users vaporize the drug, Lancelotta says, but the survey found some insufflation (snorting) and intramuscular (injection) administration, too. Like other psychedelics, it does not seem to lend itself to chronic abuse.
Unlike some other natural psychedelic substances, the discovery of 5-MeO-DMT in toad venom is relatively recent, and does not trace back to Indigenous religious or ceremonial practices. toad venom psychedelic